Kapstone Medical offers flexible and customized Phase 0 Feasibility Studies to many startups and inventors. The purpose of this study is to provide a multi-disciplinary assessment of a new medical device concept and to identify associated project risks and opportunities prior to investing more significant time and capital.
In the fast-paced environment of the medical device industry, "Should we build this?" is a question of vision. It comes from understanding clinical need and market potential. For an inventor or startup, the next critical question is "Can we build this?"
This is the essence of Phase 0 Feasibility. It is the due diligence needed to begin a longer development process by accounting for risks in each relevant discipline.
Most new product ideas begin with the identification of an unmet clinical need. However, this doesn’t always justify the start of a full New Product Development project.
Phase 0 is designed to help the early-stage company by evaluating a new product idea against four critical pillars:
Assess likely regulatory classification and pathway (e.g., 510(k) considerations). Identify applicable standards and anticipated verification and validation (V&V) requirements. Identify possible predicate/comparative systems currently on the market.
There is a big difference between an early prototype and final production run.
"Can we?" also applies to the legal right to operate. A Phase 0 feasibility study includes an informal "Freedom to Operate" (FTO) analysis.
The Kapstone team has decades of experience developing complex medical devices of all classifications.
Founded in 2007, Kapstone Medical is a full-service, single-source medical device consulting firm that provides comprehensive, multidisciplinary assistance in Quality Assurance, Regulatory Affairs, Product Development, Manufacturing Solutions, and Commercialization Support.
Kapstone Manufacturing, a separate company in the Kapstone family, is a global contract manufacturer of medical devices. Both companies' medical device experts help customers navigate a cost-effective, top quality, and expedited route to market.
Phase 0 feasibility study deliverables are customized to the needs of each project, allowing budget and timing to scale accordingly. While some items can be completed à la carte, Kapstone strongly recommends completing the technical and engineering viability, regulatory, manufacturability, and IP assessments together to ensure a comprehensive and risk-aligned feasibility report.
By answering critical questions in Phase 0, you get a head start addressing several Phase 1 deliverables while building the justification required to secure your next round of investment.
If you would like to apply this Phase 0 process to your new medical device concept, we invite you to contact Kapstone Medical for a consultation today.